# Hepatic Encephalopathy

## Length Of Authorizations

365 Days

## Prior Authorization Criteria

Is there any reason the patient cannot be changed to a medication not requiring prior approval? Acceptable reasons include:

-   Allergy to medication not requiring prior approval
-   Contraindication to or drug interaction with medication not requiring prior approval
-   History of unacceptable/toxic side effects to medication not requiring prior approval

## Step Therapy

All agents listed

1.  For a drug requiring step therapy, there must have been inadequate clinical response to a preferred alternative
2.  XIFAXAN requires a diagnosis of hepatic encephalopathy and may be approved for monotherapy or add on therapy if there has been a therapeutic failure (defined as a recurrent episode) while on lactulose

## Formulary

Gastrointestinal Agents: Hepatic Encephalopathy

| PREFERRED  | NON-PREFERRED |
|------------|---------------|
| Lactulose  |               |
| Xifaxan ST |               |

### Link to Criteria

[Gastrointestinal Agents: Hepatic Encephalopathy](https://pharmacy.medicaid.ohio.gov/sites/default/files/20220415_UPDL_Criteria_FINAL_.pdf#page=60)
